Literature DB >> 25724274

Sponge-mediated lentivirus delivery to acute and chronic spinal cord injuries.

Aline M Thomas1, Jaime L Palma2, Lonnie D Shea3.   

Abstract

The environment within the spinal cord after injury, which changes in the progression from the acute to chronic stages, limits the extent of regeneration. The delivery of inductive factors to promote regeneration following spinal cord injury has been promising, yet, few strategies are versatile to allow delivery during acute or chronic injury that would facilitate screening of candidate therapies. This report investigates the intrathecal delivery of lentiviruses for long-term expression of regenerative factors. Lentivirus-filled sponges were inserted into the intrathecal space surrounding the spinal cord, with transgene expression observed within multiple cell types that persists for 12 weeks for both intact and injured spinal cord, without any apparent damage to the spinal cord tissue. Sponges loaded with lentivirus encoding for Sonic hedgehog (Shh) were investigated for acute (delivered at 0 weeks) and chronic (at 4 weeks) injuries, and for multiple locations relative to the injury. In an acute model, sponges placed directly above the injury increased oligodendrocyte and decreased astrocyte presence. Sponges placed caudal to the injury had reduced impact on oligodendrocytes and astrocytes in the injury. In a chronic model, sponges increased oligodendrocyte and decreased astrocyte presence. Furthermore, the effect of Shh was shown to be mediated in part by reduction of Bmp signaling, monitored with an Msx2-sensitive reporter vector. The implantation of lentivirus-loaded biomaterials intrathecally provides the opportunity to induce the expression of a factor at a specified time without entering the spinal cord, and has the potential to promote gene delivery within the spinal cord, which can influence the extent of regeneration.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Gene delivery; Intrathecal delivery; Lentivirus; Macro-porous sponge; Spinal cord injury

Mesh:

Substances:

Year:  2015        PMID: 25724274      PMCID: PMC4385414          DOI: 10.1016/j.jconrel.2015.02.032

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  60 in total

1.  Long-term changes in the molecular composition of the glial scar and progressive increase of serotoninergic fibre sprouting after hemisection of the mouse spinal cord.

Authors:  Emeline Camand; Marie-Pierre Morel; Andréas Faissner; Constantino Sotelo; Isabelle Dusart
Journal:  Eur J Neurosci       Date:  2004-09       Impact factor: 3.386

2.  Delayed treatment with Rho-kinase inhibitor does not enhance axonal regeneration or functional recovery after spinal cord injury in rats.

Authors:  Yutaka Nishio; Masao Koda; Keiko Kitajo; Minoru Seto; Katsuhiko Hata; Junko Taniguchi; Hideshige Moriya; Masashi Fujitani; Takekazu Kubo; Toshihide Yamashita
Journal:  Exp Neurol       Date:  2006-04-19       Impact factor: 5.330

3.  LINGO-1 antagonist promotes functional recovery and axonal sprouting after spinal cord injury.

Authors:  Benxiu Ji; Mingwei Li; Wu-Tian Wu; Leung-Wah Yick; Xinhua Lee; Zhaohui Shao; Joy Wang; Kwok-Fai So; John M McCoy; R Blake Pepinsky; Sha Mi; Jane K Relton
Journal:  Mol Cell Neurosci       Date:  2006-09-29       Impact factor: 4.314

4.  Effects of macrophage transplantation in the injured adult rat spinal cord: a combined immunocytochemical and biochemical study.

Authors:  R Franzen; J Schoenen; P Leprince; E Joosten; G Moonen; D Martin
Journal:  J Neurosci Res       Date:  1998-02-01       Impact factor: 4.164

5.  Neurotrophin-3 gradients established by lentiviral gene delivery promote short-distance axonal bridging beyond cellular grafts in the injured spinal cord.

Authors:  Laura Taylor; Leonard Jones; Mark H Tuszynski; Armin Blesch
Journal:  J Neurosci       Date:  2006-09-20       Impact factor: 6.167

6.  Identification of BMP-4 as a signal mediating secondary induction between epithelial and mesenchymal tissues during early tooth development.

Authors:  S Vainio; I Karavanova; A Jowett; I Thesleff
Journal:  Cell       Date:  1993-10-08       Impact factor: 41.582

7.  Grafting of human bone marrow stromal cells into spinal cord injury: a comparison of delivery methods.

Authors:  Courtney Paul; Amer F Samdani; Randal R Betz; Itzhak Fischer; Birgit Neuhuber
Journal:  Spine (Phila Pa 1976)       Date:  2009-02-15       Impact factor: 3.468

8.  Minimally invasive delivery of stem cells for spinal cord injury: advantages of the lumbar puncture technique.

Authors:  Ajay Bakshi; Corey Hunter; Sharon Swanger; Angelo Lepore; Itzhak Fischer
Journal:  J Neurosurg Spine       Date:  2004-10

9.  Time-dependent changes in the microenvironment of injured spinal cord affects the therapeutic potential of neural stem cell transplantation for spinal cord injury.

Authors:  Soraya Nishimura; Akimasa Yasuda; Hiroki Iwai; Morito Takano; Yoshiomi Kobayashi; Satoshi Nori; Osahiko Tsuji; Kanehiro Fujiyoshi; Hayao Ebise; Yoshiaki Toyama; Hideyuki Okano; Masaya Nakamura
Journal:  Mol Brain       Date:  2013-01-08       Impact factor: 4.041

10.  Delayed inflammatory mRNA and protein expression after spinal cord injury.

Authors:  Kimberly R Byrnes; Patricia M Washington; Susan M Knoblach; Eric Hoffman; Alan I Faden
Journal:  J Neuroinflammation       Date:  2011-10-05       Impact factor: 8.322

View more
  8 in total

1.  Diacylglycerol lipase β inhibition reverses nociceptive behaviour in mouse models of inflammatory and neuropathic pain.

Authors:  J L Wilkerson; S Ghosh; D Bagdas; B L Mason; M S Crowe; K L Hsu; L E Wise; S G Kinsey; M I Damaj; B F Cravatt; A H Lichtman
Journal:  Br J Pharmacol       Date:  2016-04-08       Impact factor: 8.739

Review 2.  Biomaterial-Guided Gene Delivery for Musculoskeletal Tissue Repair.

Authors:  Justin L Madrigal; Roberta Stilhano; Eduardo A Silva
Journal:  Tissue Eng Part B Rev       Date:  2017-03-10       Impact factor: 6.389

Review 3.  Stem cells for spinal cord injury: Strategies to inform differentiation and transplantation.

Authors:  Nisha R Iyer; Thomas S Wilems; Shelly E Sakiyama-Elbert
Journal:  Biotechnol Bioeng       Date:  2016-09-21       Impact factor: 4.530

4.  Reducing inflammation through delivery of lentivirus encoding for anti-inflammatory cytokines attenuates neuropathic pain after spinal cord injury.

Authors:  Jonghyuck Park; Joseph T Decker; Dominique R Smith; Brian J Cummings; Aileen J Anderson; Lonnie D Shea
Journal:  J Control Release       Date:  2018-10-06       Impact factor: 9.776

Review 5.  Biomaterial-guided delivery of gene vectors for targeted articular cartilage repair.

Authors:  Magali Cucchiarini; Henning Madry
Journal:  Nat Rev Rheumatol       Date:  2019-01       Impact factor: 20.543

6.  Acupuncture combined with moxibustion promote the recovery of spinal cord injury in correlation with Shh/Gli-1 signaling pathway.

Authors:  Li-Li-Qiang Ding; Song-Feng Hu; Xing-Wei He; Peng Zhang; Fen-Fen Zhao; Ting-Ping Liu; Qin Zhang; Fan He; Ying Yu; Peng Xiong; Chang-Kang Wang
Journal:  J Spinal Cord Med       Date:  2020-05-22       Impact factor: 1.985

7.  IL-10 lentivirus-laden hydrogel tubes increase spinal progenitor survival and neuronal differentiation after spinal cord injury.

Authors:  Andrew J Ciciriello; Dominique R Smith; Mary K Munsell; Sydney J Boyd; Lonnie D Shea; Courtney M Dumont
Journal:  Biotechnol Bioeng       Date:  2021-04-23       Impact factor: 4.395

Review 8.  Hydrogel-based local drug delivery strategies for spinal cord repair.

Authors:  Robert B Shultz; Yinghui Zhong
Journal:  Neural Regen Res       Date:  2021-02       Impact factor: 5.135

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.